Article Versions Notes

Oliva EN, Candoni A, Salutari P, Palumbo GA, Reda G, Iannì G, Tripepi G, Cuzzola M, Capelli D, Mammì C, et al. Azacitidine Post-Remission Therapy for Elderly Patients with AML: A Randomized Phase-3 Trial (QoLESS AZA-AMLE). Cancers. 2023; 15(9):2441. https://doi.org/10.3390/cancers15092441

Oliva, Esther Natalie, Anna Candoni, Prassede Salutari, Giuseppe A. Palumbo, Gianluigi Reda, Giuseppe Iannì, Giovanni Tripepi, Maria Cuzzola, Debora Capelli, Corrado Mammì, and et al. 2023. "Azacitidine Post-Remission Therapy for Elderly Patients with AML: A Randomized Phase-3 Trial (QoLESS AZA-AMLE)" Cancers 15, no. 9: 2441. https://doi.org/10.3390/cancers15092441

Oliva, E. N., Candoni, A., Salutari, P., Palumbo, G. A., Reda, G., Iannì, G., Tripepi, G., Cuzzola, M., Capelli, D., Mammì, C., Alati, C., Cannatà, M. C., Niscola, P., Serio, B., Musto, P., Vigna, E., Volpe, A., Melillo, L. M. A., Arcadi, M. T., ... Latagliata, R. (2023). Azacitidine Post-Remission Therapy for Elderly Patients with AML: A Randomized Phase-3 Trial (QoLESS AZA-AMLE). Cancers, 15(9), 2441. https://doi.org/10.3390/cancers15092441